Author Correction: Spread of pathological tau proteins through communicating neurons in human Alzheimer's disease.
作者信息
Vogel Jacob W, Iturria-Medina Yasser, Strandberg Olof T, Smith Ruben, Levitis Elizabeth, Evans Alan C, Hansson Oskar
机构信息
Montreal Neurological Institute, McGill University, Montréal, QC, Canada.
Clinical Memory Research Unit, Lund University, Lund, Sweden.
出版信息
Nat Commun. 2021 Aug 5;12(1):4862. doi: 10.1038/s41467-021-25193-3.
Abstract
摘要
相似文献
1
Author Correction: Spread of pathological tau proteins through communicating neurons in human Alzheimer's disease.作者更正：病理性tau蛋白在人类阿尔茨海默病中通过相互连接的神经元传播。
Nat Commun. 2021 Aug 5;12(1):4862. doi: 10.1038/s41467-021-25193-3.
2
Conformation-selective tau monoclonal antibodies inhibit tau pathology in primary neurons and a mouse model of Alzheimer's disease.构象选择性 tau 单克隆抗体抑制原代神经元和阿尔茨海默病小鼠模型中的 tau 病理学。
Mol Neurodegener. 2020 Nov 4;15(1):64. doi: 10.1186/s13024-020-00404-5.
3
Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.α1-抗糜蛋白酶是一种在阿尔茨海默病大脑中过度表达的炎症蛋白，可诱导神经元中的tau蛋白磷酸化。
Brain. 2006 Nov;129(Pt 11):3020-34. doi: 10.1093/brain/awl255. Epub 2006 Sep 20.
4
GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.在向中枢神经系统注射阿尔茨海默病脑源性病理性tau蛋白或合成突变型人tau蛋白原纤维后，绿色荧光蛋白标记的突变型人tau转基因小鼠出现tau蛋白病。
J Neurosci. 2017 Nov 22;37(47):11485-11494. doi: 10.1523/JNEUROSCI.2393-17.2017. Epub 2017 Oct 6.
5
Proteostasis failure exacerbates neuronal circuit dysfunction and sleep impairments in Alzheimer's disease.蛋白稳态失衡加剧阿尔茨海默病中神经元回路功能障碍和睡眠障碍。
Mol Neurodegener. 2023 Apr 21;18(1):27. doi: 10.1186/s13024-023-00617-4.
6
Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.源自散发性阿尔茨海默病 iPSC 的神经元显示出 TAU 过度磷酸化增加、淀粉样蛋白水平升高和 GSK3β 激活。
Alzheimers Res Ther. 2017 Dec 1;9(1):90. doi: 10.1186/s13195-017-0317-z.
7
Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer's disease or corticobasal degeneration brains.在年轻的PS19 tau转基因小鼠脑内注射来自阿尔茨海默病或皮质基底节变性大脑的病理性tau后，tau病理变化的差异诱导和传播。
Acta Neuropathol. 2015 Feb;129(2):221-37. doi: 10.1007/s00401-014-1373-0. Epub 2014 Dec 24.
8
FRMD4A-cytohesin signaling modulates the cellular release of tau.FRMD4A-细胞粘附素信号传导调节tau蛋白的细胞释放。
J Cell Sci. 2016 May 15;129(10):2003-15. doi: 10.1242/jcs.180745. Epub 2016 Apr 4.
9
Pathological conformations involving the amino terminus of tau occur early in Alzheimer's disease and are differentially detected by monoclonal antibodies.涉及tau蛋白氨基末端的病理构象在阿尔茨海默病早期出现，并且可被单克隆抗体差异检测到。
Neurobiol Dis. 2016 Oct;94:18-31. doi: 10.1016/j.nbd.2016.05.016. Epub 2016 May 31.
10
A three-dimensional human neural cell culture model of Alzheimer's disease.一种阿尔茨海默病的三维人类神经细胞培养模型。
Nature. 2014 Nov 13;515(7526):274-8. doi: 10.1038/nature13800. Epub 2014 Oct 12.
引用本文的文献
1
Cognitive decline in community-dwelling older persons with primary age-related tauopathy: role of anatomical location of tangles and other co-existing brain pathologies.社区居住的患有原发性年龄相关性tau蛋白病的老年人的认知衰退：缠结的解剖位置及其他并存脑病理学的作用
Acta Neuropathol. 2025 Jul 24;150(1):8. doi: 10.1007/s00401-025-02916-0.
2
Liposome nanoparticle conjugation and cell penetrating peptide sequences (CPPs) enhance the cellular delivery of the tau aggregation inhibitor RI-AG03.脂质体纳米粒子缀合和细胞穿透肽序列（CPPs）增强了tau 聚集抑制剂 RI-AG03 的细胞递呈。
J Cell Mol Med. 2024 Jun;28(11):e18477. doi: 10.1111/jcmm.18477.
Zotero 插件